First Time Loading...

Corbus Pharmaceuticals Holdings Inc
NASDAQ:CRBP

Watchlist Manager
Corbus Pharmaceuticals Holdings Inc Logo
Corbus Pharmaceuticals Holdings Inc
NASDAQ:CRBP
Watchlist
Price: 42.8 USD 3.13% Market Closed
Updated: Jun 1, 2024
CRBP
/
Balance Sheet
/
Total Liabilities & Equity

Corbus Pharmaceuticals Holdings Inc
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Corbus Pharmaceuticals Holdings Inc
Total Liabilities & Equity Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Corbus Pharmaceuticals Holdings Inc
NASDAQ:CRBP
Total Liabilities & Equity
$28.3m
CAGR 3-Years
-35%
CAGR 5-Years
-10%
CAGR 10-Years
58%
Abbvie Inc
NYSE:ABBV
Total Liabilities & Equity
$148.9B
CAGR 3-Years
0%
CAGR 5-Years
21%
CAGR 10-Years
18%
Gilead Sciences Inc
NASDAQ:GILD
Total Liabilities & Equity
$56.3B
CAGR 3-Years
-6%
CAGR 5-Years
-2%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Total Liabilities & Equity
$93B
CAGR 3-Years
14%
CAGR 5-Years
8%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Liabilities & Equity
$23.9B
CAGR 3-Years
25%
CAGR 5-Years
30%
CAGR 10-Years
27%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Liabilities & Equity
$34.4B
CAGR 3-Years
25%
CAGR 5-Years
22%
CAGR 10-Years
27%

See Also

What is Corbus Pharmaceuticals Holdings Inc's Total Liabilities & Equity?
Total Liabilities & Equity
28.3m USD

Based on the financial report for Dec 31, 2023, Corbus Pharmaceuticals Holdings Inc's Total Liabilities & Equity amounts to 28.3m USD.

What is Corbus Pharmaceuticals Holdings Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
58%

Over the last year, the Total Liabilities & Equity growth was -57%. The average annual Total Liabilities & Equity growth rates for Corbus Pharmaceuticals Holdings Inc have been -35% over the past three years , -10% over the past five years , and 58% over the past ten years .

ALPHA SPREAD
Join more than 142,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.